Literature DB >> 20936359

Activated Syndecan-1 shedding contributes to mice colitis induced by dextran sulfate sodium.

Xia Wang1, Ye Chen, Yugang Song, Shaoheng Zhang, Xiaoyun Xie, Xianfei Wang.   

Abstract

BACKGROUND: Syndecan-1(Sdc1) plays important roles in many steps of inflammatory responses. In ulcerative colitis patients, decreased Sdc1 expression was observed and Sdc1 analogue heparin could improve the disease course. A better understanding of how Sdc1 functions in colitis will benefit the disease intervention. AIMS: To evaluate the role of Sdc1 in dextran sulfate sodium (DSS)-induced colitis.
METHODS: BALB/c mice were grouped randomly into control, DSS, and heparin+DSS. The DSS group was given 4% DSS orally and heparin+DSS group was given 4% DSS with heparin (enoxaparin) subcutaneously, while the control was given distilled water orally. All mice were killed at day 7. Disease activities, histopathological changes, membrane-bound and free Sdc1 level and mRNA expression of Sdc1, IL-1, and IL-10 in colon mucosa were detected.
RESULTS: Significant colitis was observed in the DSS group, but disease activity index and histological score showed significant lower in the heparin+DSS group than those in the DSS group. Compared to the control group, decreased Sdc1 protein expression was detected in colon mucosa of DSS-induced colitis while Sdc1 ectodomain level in serum was much higher. Inhibited Sdc1 ectodomain shedding was detected in the heparin+DSS group compared to the DSS group. RT-PCR demonstrated that both IL-1 and IL-10 expression were up-regulated in DSS-induced colitis while heparin lessened the up-regulation extent.
CONCLUSIONS: Sdc1 shedding is activated in DSS-induced colitis and heparin, which mimics Sdc1 functions, relieves colitis severity by inhibiting Sdc1 shedding and down-regulating cytokines expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936359     DOI: 10.1007/s10620-010-1398-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

Authors:  T Kucharzik; S V Walsh; J Chen; C A Parkos; A Nusrat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 2.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

3.  Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.

Authors:  T Kucharzik; N Lügering; H Weigelt; M Adolf; W Domschke; R Stoll
Journal:  Clin Exp Immunol       Date:  1996-06       Impact factor: 4.330

4.  Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.

Authors:  A Keshavarzian; R D Fusunyan; M Jacyno; D Winship; R P MacDermott; I R Sanderson
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

5.  Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.

Authors:  C M Hogaboam; B A Vallance; A Kumar; C L Addison; F L Graham; J Gauldie; S M Collins
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Saliva Interleukin-6 in patients with inflammatory bowel disease.

Authors:  Aneta Aleksandra Nielsen; Jens Nederby Nielsen; Anne Schmedes; Ivan Brandslund; Henrik Hey
Journal:  Scand J Gastroenterol       Date:  2005-12       Impact factor: 2.423

7.  Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.

Authors:  Martin Floer; Martin Götte; Martin K Wild; Jan Heidemann; Ezeddin Salem Gassar; Wolfram Domschke; Ludwig Kiesel; Andreas Luegering; Torsten Kucharzik
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 8.  Smad7 in TGF-beta-mediated negative regulation of gut inflammation.

Authors:  Giovanni Monteleone; Francesco Pallone; Thomas T MacDonald
Journal:  Trends Immunol       Date:  2004-10       Impact factor: 16.687

9.  Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.

Authors:  Lisa S Poritz; Kristian I Garver; Cecelia Green; Leo Fitzpatrick; Francesca Ruggiero; Walter A Koltun
Journal:  J Surg Res       Date:  2007-04-06       Impact factor: 2.192

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  11 in total

1.  Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.

Authors:  Doron Yablecovitch; Assaf Stein; Maytal Shabat-Simon; Timna Naftali; Gila Gabay; Ido Laish; Asaf Oren; Fred M Konikoff
Journal:  Dig Dis Sci       Date:  2015-02-22       Impact factor: 3.199

2.  Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.

Authors:  D Yablecovitch; A Oren; S Ben-Horin; E Fudim; R Eliakim; T Saker; F M Konikoff; U Kopylov; T Matthias; A Lerner
Journal:  Dig Dis Sci       Date:  2016-12-26       Impact factor: 3.199

3.  Plasma-Mediated Gut Protection After Hemorrhagic Shock is Lessened in Syndecan-1-/- Mice.

Authors:  Kechen Ban; Zhanglong Peng; Shibani Pati; Richard B Witkov; Pyong Woo Park; Rosemary A Kozar
Journal:  Shock       Date:  2015-11       Impact factor: 3.454

4.  Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease.

Authors:  Cem Çekiç; Adnan Kırcı; Sezgin Vatansever; Fatih Aslan; Huriye Erbak Yılmaz; Emrah Alper; Mahmut Arabul; Elif Sarıtaş Yüksel; Belkıs Ünsal
Journal:  Gastroenterol Res Pract       Date:  2015-07-29       Impact factor: 2.260

5.  Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.

Authors:  X Wang; D Zuo; Y Chen; W Li; R Liu; Y He; L Ren; L Zhou; T Deng; X Wang; G Ying; Y Ba
Journal:  Br J Cancer       Date:  2014-10-16       Impact factor: 7.640

6.  Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.

Authors:  Yan Zhang; Zhongqiu Wang; Jun Liu; Shaoheng Zhang; Jiaxi Fei; Jing Li; Ting Zhang; Jide Wang; Pyong W Park; Ye Chen
Journal:  J Cell Mol Med       Date:  2016-08-25       Impact factor: 5.310

7.  Colocalization with MMP-7 in the Distal Colon is Crucial for Syndecan-2 Shedding in Dextran Sulfate Sodium-Induced Colitis Mice.

Authors:  Heejeong Hong; Hyun-Kuk Song; Bohee Jang; Eunhye Park; Dong Soo Han; Seong-Eun Kim; Eok-Soo Oh
Journal:  J Inflamm Res       Date:  2021-09-29

Review 8.  Utilization of glycosaminoglycans by the human gut microbiota: participating bacteria and their enzymatic machineries.

Authors:  Parkash Singh Rawat; Ahkam Saddam Seyed Hameed; Xiangfeng Meng; Weifeng Liu
Journal:  Gut Microbes       Date:  2022 Jan-Dec

9.  Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses.

Authors:  Qi Ying Lean; Rajaraman D Eri; Sarron Randall-Demllo; Sukhwinder Singh Sohal; Niall Stewart; Gregory M Peterson; Nuri Gueven; Rahul P Patel
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

10.  Low molecular weight heparin relieves experimental colitis in mice by downregulating IL-1β and inhibiting syndecan-1 shedding in the intestinal mucosa.

Authors:  Xian-fei Wang; Ai-ming Li; Jing Li; Shi-yong Lin; Chu-di Chen; You-Lian Zhou; Xia Wang; Cun-long Chen; Si-de Liu; Ye Chen
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.